Not exact matches
Ackman for instance exited its
stake in troubled
pharmaceutical company Valeant
in early 2017, costing his shareholders billions.
The investigation is tied to his large
stake in Canadian drug
company Valeant
Pharmaceuticals, which has been facing more - and - more problems it seems each day.
Big
pharmaceutical companies often put
stakes in promising start - ups.
British researchers will have access to it thanks to a deal signed last week between the Medical Research Council and SmithKline Beecham, the British - based
pharmaceuticals company, which has a large
stake in the database.